Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Egan, MF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Winterer, G; Egan, MF; Radler, T; Hyde, T; Coppola, R; Weinberger, DR
      An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia (vol 49, pg 129, 2001)

      SCHIZOPHRENIA RESEARCH
    2. Winterer, G; Egan, MF; Radler, T; Hyde, T; Coppola, R; Weinberger, DR
      An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophrenia

      SCHIZOPHRENIA RESEARCH
    3. Dawson, NM; Hamid, EH; Egan, MF; Meredith, GE
      Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment

      SYNAPSE
    4. Egan, MF; Goldberg, TE; Kolachana, BS; Callicott, JH; Mazzanti, CM; Straub, RE; Goldman, D; Weinberger, DR
      Effect of COMT Val(108/158) Met genotype on frontal lobe function and riskfor schizophrenia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Winterer, G; Egan, MF; Radler, T; Coppola, R; Weinberger, DR
      Event-related potentials and genetic risk for schizophrenia

      BIOLOGICAL PSYCHIATRY
    6. Egan, MF; Goldberg, TE; Gscheidle, T; Weirich, M; Rawlings, R; Hyde, TM; Bigelow, L; Weinberger, DR
      Relative risk for cognitive impairments in siblings of patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    7. Bertolino, A; Callicott, JH; Mattay, VS; Weidenhammer, KM; Rakow, R; Egan, MF; Weinberger, DR
      The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    8. Meyer-Lindenberg, A; Poline, JB; Kohn, PD; Holt, JL; Egan, MF; Weinberger, DR; Berman, KF
      Evidence for abnormal cortical functional connectivity during working memory in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    9. Egan, MF; Hyde, TM; Bonomo, JB; Mattay, VS; Bigelow, LB; Goldberg, TE; Weinberger, DR
      Relative risk of neurological signs in siblings of patients with schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    10. Apud, JA; Egan, MF; Wyatt, RJ
      Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    11. Elvevag, B; Egan, MF; Goldberg, TE
      Memory for temporal order in patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    12. Raedler, TJ; Knable, MB; Jones, DW; Lafargue, T; Urbina, RA; Egan, MF; Pickar, D; Weinberger, DR
      In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    13. Meredith, GE; De Souza, IEJ; Hyde, TM; Tipper, G; Wong, ML; Egan, MF
      Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias

      JOURNAL OF NEUROSCIENCE
    14. Goldberg, TE; Dodge, M; Aloia, M; Egan, MF; Weinberger, DR
      Effects of neuroleptic medications on speech disorganization in schizophrenia: biasing associative networks towards meaning

      PSYCHOLOGICAL MEDICINE
    15. Elvevag, B; Egan, MF; Goldberg, TE
      Paired-associate learning and memory interference in schizophrenia

      NEUROPSYCHOLOGIA
    16. Weickert, TW; Goldberg, TE; Gold, JM; Bigelow, LB; Egan, MF; Weinberger, DR
      Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect

      ARCHIVES OF GENERAL PSYCHIATRY
    17. Egan, MF; Goldberg, TE; Gscheidle, T; Weirich, M; Bigelow, LB; Weinberger, DR
      Relative risk of attention deficits in siblings of patients with schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Callicott, JH; Bertolino, A; Egan, MF; Mattay, VS; Langheim, FJP; Weinberger, DR
      Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    19. Bower, CM; Hyde, TM; Zaka, M; Hamid, EH; Baca, SM; Egan, MF
      Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol

      PSYCHOPHARMACOLOGY
    20. Raedler, TJ; Knable, MB; Lafargue, T; Urbina, RA; Egan, MF; Pickar, D; Weinberger, DR
      In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine

      PSYCHIATRY RESEARCH-NEUROIMAGING
    21. Callicott, JH; Egan, MF; Bertlino, A; Mattay, VS; Langheim, FJP; Frank, JA; Weinberger, DR
      Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: A possible intermediate neurobiological (vol 44, pg 941, 1998)

      BIOLOGICAL PSYCHIATRY
    22. HAMID EH; HYDE TM; EGAN MF; BACHUS SE; KINKEAD BL; NEMEROFF CB; WOLF SS; HERMAN MM; KLEINMAN JE
      ABNORMALITIES IN NEUROTENSIN GENE-EXPRESSION LEVELS IN THE HIPPOCAMPUS OF SCHIZOPHRENICS

      Schizophrenia research
    23. HAMID EH; EGAN MF; DICKSON LA
      DETRIMENTAL EFFECTS OF SHORT-TERM HALOPERIDOL TREATMENT AND WITHDRAWAL ON STRIATAL BDNF GENE-EXPRESSION

      The FASEB journal
    24. BACA SM; LIPSKA BK; EGAN MF; BACHUS SE; FERGUSON JN; HYDE TM
      EFFECTS OF PREFRONTAL CORTICAL-LESIONS ON NEUROPEPTIDE AND DOPAMINE-RECEPTOR GENE-EXPRESSION IN THE STRIATUM-ACCUMBENS COMPLEX

      Brain research
    25. HAMID EH; HYDE TM; BACA SM; EGAN MF
      FAILURE TO DOWN-REGULATE NMDA RECEPTORS IN THE STRIATUM AND NUCLEUS-ACCUMBENS ASSOCIATED WITH NEUROLEPTIC-INDUCED DYSKINESIA

      Brain research
    26. CALLICOTT JH; EGAN MF; BERTOLINO A; MATTAY VS; LANGHEIM FJP; FRANK JA; WEINBERGER DR
      HIPPOCAMPAL N-ACETYL ASPARTATE IN UNAFFECTED SIBLINGS OF PATIENTS WITH SCHIZOPHRENIA - A POSSIBLE INTERMEDIATE NEUROBIOLOGICAL PHENOTYPE

      Biological psychiatry
    27. HAMID EH; BACA SM; MEREDITH GE; HYDE TM; EGAN MF
      NEUROLEPTIC DRUG EFFECTS ON SYNAPTOPHYSIN GENE-EXPRESSION LEVELS

      Biological psychiatry
    28. BERMANN KF; HOLT JL; ESPOSITO G; CALLICOTT JL; EGAN MF; VANHORN JD; BERTOLINO A; WEINBERGER DR
      BEYOND HYPOFRONTALITY IN FUNCTIONAL BRAIN IMAGING OF SCHIZOPHRENIA

      Biological psychiatry
    29. EGAN MF; WEINBERGER DR
      NEUROBIOLOGY OF SCHIZOPHRENIA

      Current opinion in neurobiology
    30. CALLICOTT JH; BERTOLINO A; MATTAY VS; PODELL D; WESCHLER M; FRANK JA; EGAN MF; WEINBERGER DR
      H-1-MRSI ABNORMALITIES IN UNAFFECTED SIBLINGS OF PATIENTS WITH SCHIZOPHRENIA - A POSSIBLE INTERMEDIATE NEUROBIOLOGICAL PHENOTYPE

      American journal of medical genetics
    31. EGAN MF; GOLDBERG TE; BIGELOW L; COPPOLA R; WESCHLER M; HOMMER D; WEINBERGER DR
      SUITABILITY OF NEUROPSYCHOLOGICAL PARAMETERS AND SACCADE FREQUENCY ASPHENOTYPES FOR GENETIC-STUDIES OF SCHIZOPHRENIA

      American journal of medical genetics
    32. KNABLE M; EGAN MF; GOLDBERG T; BIGELOW L; CANNONSPOOR E; WEINBERGER DR
      RELATIONSHIP BETWEEN ADULT CORTICAL DYSFUNCTION AND CHILDHOOD DEVELOPMENTAL ABNORMALITIES IN PATIENTS WITH SCHIZOPHRENIA - EVIDENCE FOR A NEURODEVELOPMENTAL-CORTICAL PHENOTYPE

      American journal of medical genetics
    33. BACHUS SE; HYDE TM; HERMAN MM; EGAN MF; KLEINMAN JE
      ABNORMAL CHOLECYSTOKININ MESSENGER-RNA LEVELS IN ENTORHINAL CORTEX OFSCHIZOPHRENICS

      Journal of Psychiatric Research
    34. KNABLE MB; EGAN MF; HEINZ A; GOREY J; LEE KS; COPPOLA R; WEINBERGER DR
      ALTERED DOPAMINERGIC FUNCTION AND NEGATIVE SYMPTOMS IN DRUG-FREE PATIENTS WITH SCHIZOPHRENIA - [I-123] IODOBENZAMIDE SPECT STUDY

      British Journal of Psychiatry
    35. HAMID EH; ALTEMUS M; HYDE TM; EGAN MF
      ACTIVITY-INDUCED CHANGES IN STRIATAL NEUROPEPTIDE GENE-EXPRESSION ARENOT EXCLUSIVE TO COMPULSIVE RUNNING IN A RAT MODEL OF OCD

      Biological psychiatry
    36. EGAN MF; CHRAPUSTA SJ; KAROUM F; WYATT RJ
      THE EFFECTS OF ACUTE AND CHRONIC HALOPERIDOL TREATMENT ON DOPAMINE RELEASE MEDIATED BY THE MEDIAL FOREBRAIN-BUNDLE IN THE STRIATUM AND NUCLEUS-ACCUMBENS

      Neuropsychopharmacology
    37. EGAN MF; CHRAPUSTA S; KAROUM F; LIPSKA BK; WYATT RJ
      EFFECTS OF CHRONIC NEUROLEPTIC TREATMENT ON DOPAMINE RELEASE - INSIGHTS FROM STUDIES USING 3-METHOXYTYRAMINE

      Journal of neural transmission
    38. EGAN MF; FERGUSON J; HYDE TM
      EFFECTS OF RATING PARAMETERS ON ASSESSMENT OF NEUROLEPTIC-INDUCED VACUOUS CHEWING MOVEMENTS

      Pharmacology, biochemistry and behavior
    39. EGAN MF; HURD Y; FERGUSON J; BACHUS SE; HAMID EH; HYDE TM
      PHARMACOLOGICAL AND NEUROCHEMICAL DIFFERENCES BETWEEN ACUTE AND TARDIVE VACUOUS CHEWING MOVEMENTS INDUCED BY HALOPERIDOL

      Psychopharmacology
    40. LIPSKA BK; CHRAPUSTA SJ; EGAN MF; WEINBERGER DR
      NEONATAL EXCITOTOXIC VENTRAL HIPPOCAMPAL DAMAGE ALTERS DOPAMINE RESPONSE TO MILD REPEATED STRESS AND TO CHRONIC HALOPERIDOL

      Synapse
    41. EGAN MF; FERGUSON JN; HYDE TM
      EFFECTS OF CHRONIC NALOXONE ADMINISTRATION ON VACUOUS CHEWING MOVEMENTS AND CATALEPSY IN RATS TREATED WITH LONG-TERM HALOPERIDOL DECANOATE

      Brain research bulletin
    42. HYDE TM; EGAN MF; BROWN RJ; WEINBERGER DR; KLEINMAN JE
      DIURNAL-VARIATION IN TARDIVE-DYSKINESIA

      Psychiatry research
    43. ELKASHEF AM; EGAN MF; FRANK JA; HYDE TM; LEWIS BK; WYATT RJ
      MAGNETIC-RESONANCE-IMAGING EVALUATION OF BRAIN IRON LEVELS - RESPONSE

      Biological psychiatry
    44. HYDE TM; EGAN MF; WING LL; WYATT RJ; WEINBERGER DR; KLEINMAN JE
      PERSISTENT CATALEPSY ASSOCIATED WITH 7 DYSKINESIAS IN RATS TREATED WITH CHRONIC INJECTIONS OF HALOPERIDOL DECANOATE

      Psychopharmacology
    45. EGAN MF; HYDE TM; KLEINMAN JE; WYATT RJ
      NEUROLEPTIC-INDUCED VACUOUS CHEWING MOVEMENTS IN RODENTS - INCIDENCE AND EFFECTS OF LONG-TERM INCREASES IN HALOPERIDOL DOSE

      Psychopharmacology
    46. EGAN MF; DUNCAN CC; SUDDATH RL; KIRCH DG; MIRSKY AF; WYATT RJ
      EVENT-RELATED POTENTIAL ABNORMALITIES CORRELATE WITH STRUCTURAL BRAINALTERATIONS AND CLINICAL-FEATURES IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA

      Schizophrenia research
    47. EGAN MF; HURD Y; HYDE TM; WEINBERGER DR; WYATT RJ; KLEINMAN JE
      ALTERATIONS IN MESSENGER-RNA LEVELS OF D2 RECEPTORS AND NEUROPEPTIDESIN STRIATONIGRAL AND STRIATOPALLIDAL NEURONS OF RATS WITH NEUROLEPTIC-INDUCED DYSKINESIAS

      Synapse
    48. KAROUM F; CHRAPUSTA SJ; EGAN MF
      3-METHOXYTYRAMINE IS THE MAJOR METABOLITE OF RELEASED DOPAMINE IN THERAT FRONTAL-CORTEX - REASSESSMENT OF THE EFFECTS OF ANTIPSYCHOTICS ONTHE DYNAMICS OF DOPAMINE RELEASE AND METABOLISM IN THE FRONTAL-CORTEX, NUCLEUS-ACCUMBENS, AND STRIATUM BY A SIMPLE 2-POOL MODEL

      Journal of neurochemistry
    49. KAROUM F; EGAN MF; WYATT RJ
      SELECTIVE REDUCTION IN DOPAMINE TURNOVER IN THE RAT FRONTAL-CORTEX AND HYPOTHALAMUS DURING WITHDRAWAL FROM REPEATED COCAINE EXPOSURE

      European journal of pharmacology
    50. CHRAPUSTA SJ; EGAN MF; MASSERANO JM; WYATT RJ
      DOPAMINE RELEASE IN THE RAT CEREBELLUM AND HIPPOCAMPUS - A TISSUE 3-METHOXYTYRAMINE STUDY

      Brain research
    51. KNABLE MB; HYDE TM; EGAN MF; TOSAYALI M; WYATT RJ; KLEINMAN JE
      QUANTITATIVE AUTORADIOGRAPHY OF STRIATAL DOPAMINE D1, D2 AND REUPTAKESITES IN RATS WITH VACUOUS CHEWING MOVEMENTS

      Brain research
    52. EGAN MF; WING L; LI R; KIRCH DG; WYATT RJ
      EFFECTS OF CHRONIC COCAINE TREATMENT ON RAT-BRAIN - LONG-TERM REDUCTION IN FRONTAL CORTICAL SEROTONIN

      Biological psychiatry
    53. ELKASHEF AM; EGAN MF; FRANK JA; HYDE TM; LEWIS BK; WYATT RJ
      BASAL GANGLIA IRON IN TARDIVE-DYSKINESIA - AN MRI STUDY

      Biological psychiatry
    54. KAROUM F; CHRAPUSTA SJ; EGAN MF; WYATT RJ
      ABSENCE OF 6-HYDROXYDOPAMINE IN THE RAT-BRAIN AFTER TREATMENT WITH STIMULANTS AND OTHER DOPAMINERGIC AGENTS - A MASS FRAGMENTOGRAPHIC STUDY

      Journal of neurochemistry
    55. EGAN MF; DARGHAM AA; KIRCH DG; WYATT RJ
      SERUM CREATINE-PHOSPHOKINASE ELEVATIONS IN PATIENTS WITH TARDIVE-DYSKINESIA

      British Journal of Psychiatry
    56. EGAN MF; HYDE TM; ELKASHEF A; WYATT RJ
      VITAMIN-E TREATMENT OF TARDIVE-DYSKINESIA - REPLY

      The American journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 14:32:10